Kiromic BioPharma KRBP

$ 3.15 6.61%

Quarterly report 2024-Q3
added 11-08-2024

Kiromic BioPharma Balance Sheet 2011-2024 | KRBP

Annual Balance Sheet Kiromic BioPharma

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	1.48 M	-	-10.2 K	-1.93 M	-384 K	-	-	-	-	-	-	-
Long Term Debt	1.54 M	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	584 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	13.3 M	3.41 M	1.47 M	-	-	-	-	-	-	-	-	-
Total Liabilities	17.7 M	3.41 M	1.47 K	674 K	611 K	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-102 M	-67.2 M	-	-22.4 M	-18.7 M	-	-	-	-	-	-	-
Total Assets	12 M	30.7 M	12.8 K	2.65 M	876 K	-	-	-	-	-	-	-
Cash and Cash Equivalents	645 K	25.4 M	10.2 M	1.93 M	-	-	-	-	-	-	-	-
Book Value	-5.77 M	27.3 M	11.4 K	1.98 M	265 K	-	-	-	-	-	-	-
Total Shareholders Equity	-5.77 M	27.3 M	11.4 M	1.98 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Kiromic BioPharma

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	404 K	577 K	912 K	1.07 M	1.23 M	1.39 M	1.54 M	1.63 M	1.77 M	1.75 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	19.5 M	17.6 M	21.3 M	18.7 M	19.9 M	21.2 M	17.7 M	12.7 M	7.74 M	5.86 M	3.41 M	1.44 M	1.57 M	1.7 M	1.47 M	1.47 M	1.47 M	1.47 M	674 K	674 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-143 M	-136 M	-123 M	-118 M	-114 M	-107 M	-102 M	-94.9 M	-83 M	-74.6 M	-67.2 M	-56.6 M	-50.5 M	-45.5 M	-41.6 M	-41.6 M	-41.6 M	-41.6 M	-22.4 M	-22.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	10.2 M	12.5 M	12.2 M	14.2 M	13.6 M	13.1 M	12 M	13 M	19.5 M	25.9 M	30.7 M	39 M	6.44 M	10.2 M	12.8 M	12.8 M	12.8 M	12.8 M	2.65 M	2.65 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.92 M	4.05 M	3.2 M	4.38 M	2.7 M	2.05 M	645 K	433 K	6.51 M	15.1 M	25.4 M	35.2 M	3.07 M	7.34 M	10.2 M	10.2 M	10.2 M	10.2 M	1.93 M	1.93 M	-	-	384 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-9.29 M	-5.17 M	-9.12 M	-4.49 M	-6.29 M	-8.14 M	-5.77 M	284 K	11.8 M	20 M	27.3 M	37.5 M	4.87 M	8.45 M	11.4 M	11.4 M	11.4 M	11.4 M	1.98 M	1.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-9.29 M	-5.17 M	-9.12 M	-4.49 M	-6.29 M	-8.14 M	-5.77 M	284 K	11.8 M	20 M	27.3 M	37.5 M	4.87 M	8.45 M	11.4 M	11.4 M	11.4 M	11.4 M	1.98 M	1.98 M	-197 K	-21.6 K	265 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency